Azilsartan Medoxomil Tablet
NDC Package 70748-237-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Azilsartan Medoxomil tablets is azilsartan is used to treat high blood pressure (hypertension). This formulation utilizes a tablet delivery system. Marketed by Lupin Pharmaceuticals, Inc., this product is identified by NDC 70748-237 and is authorized under FDA application ANDA214489.

Identification & Billing

NDC Package Code
70748-237-06
Package Description
30 TABLET in 1 BOTTLE
Product Code
70748-237
11-Digit Billing Format
70748023706
RxNorm Crosswalk
  • RxCUI: 1091646 - azilsartan medoxomil 40 MG Oral Tablet
  • RxCUI: 1091646 - azilsartan medoxomil 40 MG (equivalent to azilsartan kamedoxomil 42.68 MG) Oral Tablet
  • RxCUI: 1091652 - azilsartan medoxomil 80 MG Oral Tablet
  • RxCUI: 1091652 - azilsartan medoxomil 80 MG (equivalent to azilsartan kamedoxomil 85.36 MG) Oral Tablet

Clinical Specifications

Proprietary Name
Azilsartan Medoxomil
Non-Proprietary Name
Azilsartan Medoxomil
Substance Name
Azilsartan Kamedoxomil
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
AZILSARTAN KAMEDOXOMIL 80 mg/1
Pharmacologic Class
Usage Information
Azilsartan is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Azilsartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.

Regulatory & Marketing

Labeler Name
Lupin Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA214489
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-14-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70748-237-06 identifies a specific commercial package of 30 tablet in 1 bottle of Azilsartan Medoxomil, a human prescription drug labeled by Lupin Pharmaceuticals, Inc.. This tablet is formulated for oral use and contains azilsartan kamedoxomil as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lupin Pharmaceuticals, Inc. on May 14, 2026. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Azilsartan is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Azilsartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.

How is this Lupin Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70748023706. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70748-237-06
11-Digit CMS (5-4-2)
70748-0237-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.